Stay updated on Phase II Anti-PD1 Epigenetic Therapy Clinical Trial

Sign up to get notified when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.4 to v3.5.5, indicating a minor system update; the study details and user-facing content appear unchanged.
    Difference
    0.0%
    Check dated 2026-06-05T09:23:49.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page revision label changed from v3.5.3 to v3.5.4, indicating a new build or update. No study content or data appears to be changed by this update.
    Difference
    0.0%
    Check dated 2026-05-15T04:14:06.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    A new revision tag (v3.5.3) replaces the previous tag (v3.5.2), signaling an update to the page's version.
    Difference
    0.0%
    Check dated 2026-04-30T17:41:50.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 on the page.
    Difference
    0.0%
    Check dated 2026-04-16T10:45:08.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-18T15:41:35.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a site version update with no changes to study data or participant information.
    Difference
    0.0%
    Check dated 2026-03-11T16:09:47.000Z thumbnail image

Stay in the know with updates to Phase II Anti-PD1 Epigenetic Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.